PD-021Bevacizumab (BV) maintenance after first-line chemotherapy plus BV for metastatic colorectal cancer patients: a meta-analysis of individual patients data from 3 phase III studies. (2nd July 2019) - Salvatore, L; Bria, E; Sperduti, I; Hinke, A; Hegewisch-Becker, S; Aparicio, T; Le Malicot, K; Boige, V; Koeberle, D; Baertschi, D; Dietrich, D; Tortora, G; et al.